Latest News

Hormonal contraception and the risk of HIV acquisition
WHO | 9 August 2016
The expert review group will assess whether current WHO guidance needs to change in the light of a new review of data, published in AIDS on 9 August 2016, which was commissioned by WHO. For the past 25 years, there has been mixed evidence as to whether use of hormonal contraceptive methods (particularly depot medroxyprogesterone acetate [DMPA]) is associated with a woman’s risk of acquiring HIV. WHO is committed to engaging with stakeholders and has been continuously monitoring and...
Ebola, Zika & Zoonotic Disease Threats in Africa
The Brenthurst Foundation | 4 August 2016
Professor Janusz Paweska of the National Institute of Communicable Diseases will present the main findings of the Brenthurst Foundation Special Report “Unnecessary Ebola-Related Deaths” by Helen Epstein) and especially the aspects on the West African Ebola outbreak response in which he was directly involved. He will provide an update of how Sierra Leone and Liberia are dealing with the aftermath of the Ebola epidemic. He will also share with the audience where we are with the Zika...
Family planning is a key development goal that needs greater investment
The Guardian | 1 August 2016
Family planning is much more than a vital health and human rights intervention (Critical moment for family planning as funds come under pressure, 28 July). Investments in voluntary family planning are also investments in sustainable development, and therefore should be of as much of concern to ministers of finance as to ministers of health.
Aids research: High risk, top science
Financial Mail | 29 July 2016
SA is at the epicentre of the global HIV/Aids epidemic, and its scientists are at the very heart of the quest to stop it in its tracks. No other high-burden country has the same scientific capacity, placing SA in a unique position to contribute to game-changing research, says Anthony Fauci, director of the National Institutes of Allergy & Infectious Diseases at the US National Institutes of Health (NIH). “SA is truly unique in this respect. There are some other countries in...
Next HIV plan needs to be based on latest evidence
Health-e News | 29 July 2016
We are on the brink of getting a new National Strategic Plan (NSP) for HIV, TB and STIs, and it is vital that the new plan avoids the mistakes of the past At the end of this year South Africa’s big plan to fight HIV and tuberculosis (TB) comes to an end. The National Strategic Plan (NSP) for HIV, TB and STIs 2012 – 2016 will be replaced by the 2017 – 2021 NSP. It is vital that the new NSP avoids the mistakes of the past and fully incorporates new scientific evidence. It is...
Announcement: University of the Western Cape to host the World Nutrition Conference
University of the Western Cape | 27 July 2016
This August, global experts and thought leaders in the field of Public Health, World Nutrition and Food Systems, will meet in Cape Townfor the 2nd edition of the World Public Health Nutrition Association’s (WPHNA) World Nutrition Congress.   From 30 August – 2 September the University of the Western Cape will host the World Nutrition Conference 2016, where renowned public health experts will take to the stage to discuss, debate and share insights on how toaddress the double...
UCT’s Drug Discovery and Development Centre, H3D, identifies a second potent anti-malarial candidate
UCT | 27 July 2016
The University of Cape Town (UCT)’s Drug Discovery and Development Centre, H3D, has identified a new potent anti-malarial development candidate with potential for both treatment and prevention of malaria. The compound, referred to as UCT943, is the second preclinical candidate to come out of the collaboration led by H3D involving the Switzerland-based Medicines for Malaria Venture (MMV) and an international network of partners.
AIDS2016: HIV and hypertension a growing problem
IOL | 22 July 2016
Three-quarters of people on antiretroviral treatment at a clinic in Khayelitsha were also being treated for hypertension. Yet there is not enough information about how HIV and common non-communicable diseases (NCDs) such as hypertension and diabetes interact, or how medicines to treat them interact. This is according to Dr Tolu Oni, from the University of Cape Town, who is investigating the “collision” between HIV and NCDs. “As people living with HIV are living longer,...
AIDS 2016 Daily Review
IAS | 22 July 2016
“Where are the men?” is a frequent refrain in HIV prevention, but on Thursday the AIDS 2016 symposia session, “Engaging Men in Care in HIV Treatment: Closing the Treatment and Survival Gap,” turned the spotlight to men’s participation in treatment. The data show that men living with HIV not only engage in treatment at lower levels than women…they also experience worse outcomes, including a 37% higher likelihood of death than women when on HIV treatment....
AIDS2016: How a rural community helps each other stay on HIV treatment
Bhekisisa | 21 July 2016
An adherence club helped almost all patients stay on their treatment. It is mid-morning in the small town of Eshowe in Zululand. A group of women sit in a queue in front of King Dinizulu clinic. Next to the clinic, rows of yellow ANC posters with the smiling face of President Jacob Zuma are lined up along the netball court in front of the community hall. Minenhle Sibiya watches her two-year-old son, Ndalwenhle, run around the empty part of the court. "When I heard I had HIV, I was...
AIDS2016: 20% of adults refuse HIV treatment
IOL | 21 July 2016
Perceptions of their own health can lead people living with HIV to refuse treatment, a South African study has found. Over 1 000 people were enrolled in the study, conducted in Gugulethu and Soweto, which mapped their health over a six-month period. The average age of participants was 35 and 57 percent were unemployed. Presenting the results in a session titled “Understanding the underserved” at the International AIDS Conference 2016 in Durban, physician-scientist Dr Ingrid...
AIDS2016: Ratchet up efficiency, Gates advises Special Features
IOL | 21 July 2016
Durban - If we're going to treat twice as many people with HIV, we need to double our efficiency because we’re not going to get double the money, billionaire philanthropist Bill Gates has warned. Speaking at a special session of the International Aids Conference in Durban on Wednesday, Gates – whose foundation is the biggest private funder of efforts to end HIV – said the world economy was under pressure. “There are a lot of distractions – the...